Taoyuan, Taiwan

Mei-Hui Lin

This inventor holds 1 USPTO granted patent. Top assignee: Chang Gung University. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mei-Hui Lin. Retrieved from https://idiyas.com/inventor/mei-hui-lin-9ho4s91b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Inventor Mei-Hui Lin

Introduction

Mei-Hui Lin is a notable inventor based in Tao-Yuan, Taiwan. He has made significant contributions to the field of biofilm research, particularly through his innovative patent. His work focuses on the inhibition of biofilm formation, which is crucial in various medical and industrial applications.

Latest Patents

Mei-Hui Lin holds a patent titled "Inhibition of biofilm formation by 1,2,3,4,6-penta-O-galloyl-D-glucopyranose." This patent discloses an anti-biofilm composition and a method to inhibit or prevent cell adhesion and/or biofilm formation by microorganisms. The use of 1,2,3,4,6-penta-O-galloyl-D-glucopyranose (PGG) is central to this innovative approach.

Career Highlights

Mei-Hui Lin is affiliated with Chang Gung University, where he continues to advance his research and contribute to the academic community. His work has garnered attention for its potential applications in healthcare and environmental management.

Collaborations

Some of his notable coworkers include Shih-Tung Liu and Fang-Rong Chang, who have collaborated with him on various research projects.

Conclusion

Mei-Hui Lin's innovative work in biofilm inhibition showcases the importance of research in developing solutions to complex biological challenges. His contributions are paving the way for advancements in both medical and industrial fields.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…